Members
CFAO South Africa: Expanding Access to High-Quality Medicines
CFAO South Africa, a proud member of the French South African Chamber of Commerce and Industry (FSACCI), has officially launched CFAO Healthcare SA in October 2024, reinforcing its commitment to enhancing pharmaceutical access in one of Africa’s most dynamic markets.
As part of the CFAO Group, with over 75 years of expertise, operations in 24 African countries, and nearly €2 billion in annual sales, CFAO Healthcare is dedicated to delivering sustainable healthcare solutions across the continent.
Expanding into South Africa, Africa’s second-largest pharmaceutical market, aligns with CFAO’s pan-African growth strategy. Through the acquisition of Opella Healthcare South Africa, CFAO Healthcare strengthens its distribution, medical promotion, and regulatory compliance while broadening its portfolio into new product categories.
What sets CFAO Healthcare SA apart is its integrated business model, offering import, distribution, regulatory compliance, local manufacturing, and medical promotion through its partner Ethica South Africa. This approach provides unparalleled support for manufacturers looking to navigate African markets with top-tier regulatory compliance.
As an FSACCI member, CFAO SA leverages strong business networks to establish South Africa as a strategic hub for expanding healthcare solutions across the continent, ensuring greater access to essential medicines.
Read more here: CFAO South Africa
